Baldwin Brothers Inc. MA Sells 1,955 Shares of Agilent Technologies Inc (NYSE:A)

Baldwin Brothers Inc. MA cut its stake in shares of Agilent Technologies Inc (NYSE:A) by 2.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 65,890 shares of the medical research company’s stock after selling 1,955 shares during the quarter. Baldwin Brothers Inc. MA’s holdings in Agilent Technologies were worth $6,651,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently made changes to their positions in A. State Street Corp lifted its holdings in shares of Agilent Technologies by 0.4% in the 1st quarter. State Street Corp now owns 13,574,513 shares of the medical research company’s stock worth $974,623,000 after acquiring an additional 50,304 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Agilent Technologies by 4.8% in the 1st quarter. Invesco Ltd. now owns 5,018,454 shares of the medical research company’s stock worth $359,422,000 after acquiring an additional 228,244 shares during the last quarter. Cantillon Capital Management LLC lifted its holdings in shares of Agilent Technologies by 1.0% in the 2nd quarter. Cantillon Capital Management LLC now owns 4,157,384 shares of the medical research company’s stock worth $367,389,000 after acquiring an additional 42,502 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Agilent Technologies by 42.5% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,843,379 shares of the medical research company’s stock worth $162,899,000 after acquiring an additional 550,105 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in shares of Agilent Technologies by 18.9% in the 2nd quarter. First Trust Advisors LP now owns 1,759,848 shares of the medical research company’s stock worth $155,518,000 after acquiring an additional 280,002 shares during the last quarter.

Several brokerages recently commented on A. BofA Securities lifted their target price on shares of Agilent Technologies from $99.00 to $103.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 19th. Credit Suisse Group lifted their target price on shares of Agilent Technologies from $53.00 to $54.00 and gave the stock a “neutral” rating in a research note on Monday, July 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of Agilent Technologies in a research note on Wednesday, August 19th. Citigroup lifted their target price on shares of Agilent Technologies from $85.00 to $100.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 19th. Finally, Robert W. Baird lifted their target price on shares of Agilent Technologies from $87.00 to $104.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 19th. Fifteen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Agilent Technologies currently has a consensus rating of “Hold” and an average price target of $87.95.

In related news, SVP Dominique Grau sold 6,485 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $100.00, for a total value of $648,500.00. Following the transaction, the senior vice president now owns 104,154 shares in the company, valued at approximately $10,415,400. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 72,716 shares of the company’s stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $95.76, for a total transaction of $6,963,284.16. Following the completion of the transaction, the chief executive officer now owns 575,215 shares in the company, valued at approximately $55,082,588.40. The disclosure for this sale can be found here. Insiders sold a total of 85,392 shares of company stock worth $8,219,555 over the last ninety days.

Shares of NYSE:A traded up $1.38 during midday trading on Friday, reaching $106.70. The company’s stock had a trading volume of 1,039,366 shares, compared to its average volume of 1,892,814. The firm has a 50 day moving average of $100.24 and a 200-day moving average of $89.64. The firm has a market capitalization of $32.90 billion, a P/E ratio of 48.28, a PEG ratio of 3.27 and a beta of 1.04. The company has a quick ratio of 1.90, a current ratio of 2.47 and a debt-to-equity ratio of 0.46. Agilent Technologies Inc has a 12-month low of $61.13 and a 12-month high of $107.54.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 18th. The medical research company reported $0.78 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.12. The firm had revenue of $1.26 billion for the quarter, compared to the consensus estimate of $1.21 billion. Agilent Technologies had a net margin of 13.23% and a return on equity of 20.57%. The company’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.76 EPS. On average, research analysts predict that Agilent Technologies Inc will post 3.22 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Monday, October 5th. Agilent Technologies’s dividend payout ratio is presently 23.15%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: What is the Consumer Price Index (CPI)?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply